Generic Version of Amitiza Now Available
The Company has begun shipping both the 8mcg and 24mcg capsules; the capsules are supplied in 60-count bottles.
Irritable Bowel Syndrome
MPR Weekly Dose Podcast Episode 39
This week we cover the latest in the rapidly shifting perception of chloroquine and hydroxychloroquine; The polio vaccine as a potential protector against COVID-19; A new approval for Gardasil 9; And the American Gastroenterological Association draw up new guidelines for probiotic use as a treatment in gastrointestinal disorders.
‘Dead’ Probiotic Treatment May Help Reduce Irritable Bowel Symptoms
Significantly more patients receiving nonviable probiotic vs placebo had relief of IBS symptoms.
Timing of Biologic/JAK Inhibitor Treatment Initiation in IBD Patients Examined
According to new research over 1 in 5 patients with inflammatory bowel disease (IBD) should have started treatment with an advanced systemic therapy earlier in their disease.
FDA Approves First-in-Class Treatment for IBS-C
The Food and Drug Administration (FDA) has approved Ibsrela (tenapanor; Ardelyx) for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults. Ibsrela is a locally-acting inhibitor of the sodium/hydrogen exchanger 3 (NHE3), an antiporter expressed on the apical surface of the small intestine and colon primarily responsible for the absorption of dietary sodium.…
Zelnorm Available Again for IBS-C Treatment in Women
Zelnorm (tegaserod; Alfasigma) is available again for the treatment of irritable bowel syndrome with constipation (IBS-C) in adult women <65 years of age
Is Peppermint Oil an Effective Treatment for Irritable Bowel Syndrome?
Peppermint oil (PO) was found to be safe and effective in treating pain and global symptoms associated with irritable bowel syndrome (IBS) in adult patients, according to the results of a recently published systematic review and meta-analysis.
Pregabalin Evaluated in Patients With Irritable Bowel Syndrome
Results of a recently published trial suggested pregabalin, a calcium channel alpha-2 delta ligand, may reduce gastrointestinal symptoms of irritable bowel syndrome.
Novel Blood Test for Irritable Bowel Syndrome Now Available
The test works by measuring levels of anti-cytolethal distending toxin B (CdtB) and anti-vinculin, 2 biomarkers of post-infectious IBS-D and IBS-M.
Tenapanor NDA Submitted for Irritable Bowel Syndrome With Constipation
Tenapanor, a minimally-systemic small molecule, inhibits the sodium transporter NHE3 and reduces sodium absorption in the gastrointestinal tract, thus increasing intestinal fluid.
